Coriolis Pharma is a globally operating contract research and development organization (CRDO) and a premier partner for drug product development, analytical, and manufacturing services across a vast array of therapeutic modalities. The company’s expert scientists design and execute both platform and custom services to accelerate and derisk programmes from the outset and throughout the entire product lifecycle. Providing cutting-edge formulation technologies and state-of-the-art analytical methods, Coriolis supports clients from early development stages to commercialization. As one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines, Coriolis is a privately held and independent entity comprising an interdisciplinary team of highly skilled scientists and an expert scientific advisory board.

Services include:
- Contract Research
- Laboratory and Analytical Services
- Clinical Dose
- Analytical Services
- Formulation Development
- Process Development
- Stability Studies
- Quality Control and Quality Assurance
- Regulatory Support
- Biopharmaceutical Manufacturing

Coriolis is committed to delivering innovative solutions tailored to meet the specific needs of its clients in the pharmaceutical industry. For more information, please visit coriolis-pharma.com.